Bradley E. Chipps, MD

93. Luskin, AT, Chipps BE, Rasouliyan, L, Miller, DP, Haselkorn, T, and Dorenbaum, A. Impact of asthma exacerbations and asthma triggers on asthma-related quality-of-life in patients with severe or difficult-to-treat asthma. The Journal of Allergy and Clinical Immunology: In Practice 2014 (In Press).

92. Chipps, BE, Anderson, CT, and Harder, J. Fractional exhaled nitric oxide of at least 100 and implications for future asthma research. Ann Allergy Asthma Immunol 2014;113:118-19.

91. Tashkin DO, Chipps BE, Trudo F, Zangrilli JG: Fixed airflow obstruction in asthma: a descriptive study of patient profiles and effect. J Asthma 2014 Feb 14. doi:10.3109/02770903.2014.895012 (Epub ahead of print)

90. Cleveland, C., Stewart, L., Chipps, B.E., and Spahn J.D. Diagnosis of Asthma in Preschool-Age Children. Clinical Asthma: Theory and Practice 2014. Chapter 6;57-64.

89. Schatz, M., Zeiger, R., Chipps, B., Dorenbaum, A., Chen, W., Hsu, J. Miller, D. and Mink, D. Phenotypes Determined by Cluster Analysis in Severe or Difficult-to-treat Asthma. J Allergy Clin Immunol 2013;133(6):1549-1556.

88. Kharrazi, M., Prach, L., Chipps, B., et al. Novel CFTR Variants Identified During the First Three Years of Cystic Fibrosis Newborn Screening in California. The Journal of Molecular Diagnostics 2013.

87. Chipps, B., and Mellon, M. Asthma. Encyclopedia of Inflammatory Diseases 2013 .

86. Chipps, B. Update in Pediatric Anaphylaxis: A Systemic Review. Clinical Pediatrics 2013;52(5):447-57.

85. Chipps, B., Zeiger, R., Dorenbaum, A., Borish, L., Wenzel, S., Miller, D., Hayden, M., Bleecker, E., Simons, E., Szefler, S., Weiss, S., Haselkorn, T., and TENOR Study Group. Assessment of asthma control and asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) observational cohort. Current Respiratory Care Reports 2012;1:259–269.

84. Chipps, B., Figliomeni, M., and Spector, S. Omalizumab: An Update on Efficacy and Safety in Moderate-to-Severe Allergic Asthma. Allergy and Asthma Proceedings 2012;33:377-85.

83. Chipps, B., Zeiger, R., Borish, L., Wenzel, S., Yegin, A., Hayden, M., Miller, D., Bleecker, E., Simons, E., Szefler, S., Weiss, S., and Haselkorn, T. Key Findings and Clinical Implications from the Epidemiology and Natural History of Asthma: Outcomes and T reatment Regiments (TENOR) Study. J Allergy Clin Immunol. 2012;130:332-42.

82. Zeiger, R., Yegin, A., Simons, E.R., Haselkorn, T., Rasouliyan, L., Szefler, S., Chipps, B.E., and the TENOR study group. Evaluation of the National Heart, Lung, and Blood Institute guidelines impairment domain for classifying asthma control and predicting asthma exacerbations. Ann Allergy Asthma Immunol. 2012;108:81-87.